|
|
||||||||
The Journal of Immunology, Vol 155, Issue 4 1694-1702, Copyright © 1995 by American Association of Immunologists
ARTICLES |
NN Berg and HL Ostergaard
Department of Immunology, University of Alberta, Edmonton, Canada.
Purified intercellular adhesion molecule-1 (ICAM-1), a ligand of the LFA-1, was used to analyze the contribution of ICAM-1 to the activation of CTL. ICAM-1 facilitates degranulation when co-immobilized with substimulatory amounts of anti-CD3. This facilitated response is most likely mediated through LFA-1, since Abs to this molecule significantly inhibit the response, Interestingly, when ICAM-1 and anti-CD3 are immobilized on separate beads and presented to the CTL, no ICAM-1- enhanced degranulation is observed. The ICAM-1 and anti-CD3 must be immobilized on the same surface to augment the response, suggesting that ICAM-1 either does not transmit signals into the cell or it transmits a very localized signal, since the ICAM-1 and anti-CD3 must be juxtaposed. Consistent with this finding, we demonstrate that ICAM-1 does not induce tyrosine phosphorylation or a Ca(2+)-flux in the CTL clone, but does potentiate these responses when co-immobilized with substimulatory anti-CD3. Finally ICAM-1 and anti-CD3 must be immobilized on the same bead for stable adhesion of CTL to ICAM-1. When ICAM-1 and anti-CD3 are immobilized on separate beads, there is only a transient, low level of adhesion to the ICAM-1 beads. Taken together, these results suggest that LFA-1 is acting principally as an adhesion molecule, with respect to ICAM-1, in CTL and that this adhesion is regulated through the TCR complex.
This article has been cited by other articles:
![]() |
T. L. Lysechko and H. L. Ostergaard Differential Src Family Kinase Activity Requirements for CD3{zeta} Phosphorylation/ZAP70 Recruitment and CD3{epsilon} Phosphorylation J. Immunol., June 15, 2005; 174(12): 7807 - 7814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, H. Hayashi, R. Harrison, B. Chiu, J. R. Chan, H. L. Ostergaard, R. D. Inman, J. Jongstra, M. I. Cybulsky, and J. Jongstra-Bilen Modulation of Mac-1 (CD11b/CD18)-Mediated Adhesion by the Leukocyte-Specific Protein 1 Is Key to Its Role in Neutrophil Polarization and Chemotaxis J. Immunol., July 1, 2002; 169(1): 415 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
V N Foltyn and T D Golan In vitro ultraviolet irradiation induces pro-inflammatory responses in cells from premorbid SLE mice Lupus, April 1, 2001; 10(4): 272 - 283. [Abstract] [PDF] |
||||
![]() |
J. Geginat, G. Bossi, J. R. Bender, and R. Pardi Anchorage Dependence of Mitogen-Induced G1 to S Transition in Primary T Lymphocytes J. Immunol., May 1, 1999; 162(9): 5085 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-T. Ni, M. J. Deeths, W. Li, D. L. Mueller, and M. F. Mescher Signaling Pathways Activated by Leukocyte Function-Associated Ag-1-Dependent Costimulation J. Immunol., May 1, 1999; 162(9): 5183 - 5189. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abraham, J. Griffith, and J. Miller The Dependence for Leukocyte Function-Associated Antigen-1/ICAM-1 Interactions in T Cell Activation Cannot Be Overcome by Expression of High Density TCR Ligand J. Immunol., April 15, 1999; 162(8): 4399 - 4405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Berg, L. G. Puente, W. Dawicki, and H. L. Ostergaard Sustained TCR Signaling Is Required for Mitogen-Activated Protein Kinase Activation and Degranulation by Cytotoxic T Lymphocytes J. Immunol., September 15, 1998; 161(6): 2919 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Zuckerman, L. Pullen, and J. Miller Functional Consequences of Costimulation by ICAM-1 on IL-2 Gene Expression and T Cell Activation J. Immunol., April 1, 1998; 160(7): 3259 - 3268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Holland and T. Owens Signaling through Intercellular Adhesion Molecule 1(ICAM-1) in a B Cell Lymphoma Line. THE ACTIVATION OF Lyn TYROSINE KINASE AND THE MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY J. Biol. Chem., April 4, 1997; 272(14): 9108 - 9112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |